Company Contents
Quick Facts & Snapshot
Summary
The Blood Collection Tubes market is in a sustained growth phase, driven by rising diagnostic volumes, safety-engineered devices, and automation-ready designs. Global leaders such as Becton, Dickinson and Company, Greiner Bio-One, and Terumo capture significant share through broad portfolios and scale. From US$ 5.21 Billion in 2025 to US$ 8.10 Billion by 2032, the market compounds at 6.50%.
Source: Secondary Information and ReportMines Research Team - 2026
Ranking Methodology
The ranking of leading Blood Collection Tubes market companies is based on a composite scoring model integrating quantitative and qualitative criteria. Core inputs include 2025 Blood Collection Tubes revenue, multi-year growth momentum, global versus regional market share, and the scale of installed base across hospitals, diagnostic chains, and blood banks. We additionally assess technology differentiation, breadth of product portfolio across vacuum tubes, capillary tubes, and safety devices, and compatibility with pre-analytical automation. Service coverage, distribution depth in emerging markets, regulatory track record, and the ability to support long-term supply and OEM contracts are weighted heavily. Scores from each dimension are normalized and combined into an overall competitiveness index, with cross-checks against disclosed financials, third-party benchmarks, and expert interviews to minimize bias and ensure an objective, data-driven view of Blood Collection Tubes market companies.
Top 10 Companies in Blood Collection Tubes
Source: Secondary Information and ReportMines Research Team - 2026
Detailed Company Profiles
Becton, Dickinson and Company (BD)
BD is the global leader in blood collection systems, offering comprehensive pre-analytical solutions for hospitals, labs, and blood banks worldwide.
Greiner Bio-One International GmbH
Greiner Bio-One specializes in innovative pre-analytical solutions, with strong presence in clinical diagnostics and biotechnology segments.
Terumo Corporation
Terumo is a diversified medical technology company, offering integrated blood collection, transfusion, and hospital consumable solutions.
Sarstedt AG & Co. KG
Sarstedt provides high-quality blood collection systems and laboratory consumables, emphasizing reliability and integration with lab workflows.
Vacutest Kima s.r.l.
Vacutest Kima focuses on vacuum blood collection tubes and related IVD consumables, serving both branded and OEM markets.
Narang Medical Limited
Narang Medical is a broad-based medical disposables manufacturer offering competitively priced blood collection products for emerging markets.
FL MEDICAL s.r.l.
FL MEDICAL produces blood collection tubes and labware, targeting distributors seeking customizable, mid-priced solutions.
Improve Medical Instruments Co., Ltd.
Improve Medical is a Chinese IVD consumables manufacturer expanding globally with cost-competitive blood collection products.
Weigao Group Medical Polymer Co., Ltd.
Weigao is a major Chinese medical polymer manufacturer supplying a wide range of disposables, including blood collection tubes.
Cardinal Health, Inc.
Cardinal Health is a global healthcare services and products company, emphasizing distribution and private-label medical supplies.
SWOT Leaders
Becton, Dickinson and Company (BD)
SWOT Snapshot
Global scale, extensive installed base, comprehensive portfolio, and deep integration with automation and analyzer platforms.
Premium pricing versus regional competitors, exposure to tender-driven price erosion, and complex global manufacturing footprint.
Growth in safety-engineered devices, data-enabled tubes, and rising diagnostic volumes in emerging markets and aging societies.
Aggressive low-cost competition, regulatory scrutiny on device safety, and potential supply chain disruptions for polymers and additives.
Greiner Bio-One International GmbH
SWOT Snapshot
Strong European brand, high product quality, and innovation track record in pre-analytical and specialty collection tubes.
Less scale than BD and Terumo, and uneven distribution depth in some developing regions.
Expansion into molecular and genetic testing workflows and targeted growth in Asia-Pacific and Latin America.
Increasing competition from Asian OEMs, currency volatility in export markets, and hospital consolidation squeezing margins.
Terumo Corporation
SWOT Snapshot
Integrated blood management portfolio, strong presence in Asia, and high manufacturing quality standards.
Lower brand recognition in some Western markets and dependence on hospital capital and procedural volumes.
Rising healthcare investments in Asia, demand for premium safety products, and cross-selling with transfusion solutions.
Regional pricing pressure, regulatory changes impacting import requirements, and evolving clinical protocols reducing tube utilization.
Blood Collection Tubes Market Regional Competitive Landscape
North America remains the largest revenue contributor, driven by high testing volumes, strong reimbursement, and rapid adoption of safety-engineered devices. Becton, Dickinson and Company (BD) and Cardinal Health dominate hospital and reference lab channels, while buyers increasingly pursue multi-year, volume-based contracts with Blood Collection Tubes market companies to secure supply and capture price advantages.
Europe shows balanced growth, with Greiner Bio-One, Sarstedt, and BD leading in clinical laboratories and blood banks. Stringent regulations, strong worker safety norms, and rapid automation drive demand for high-quality, automation-compatible tubes. Regional distributors increasingly align with Blood Collection Tubes market companies that can provide sustainable materials and reliable supply to support large national health systems.
Asia-Pacific delivers the fastest growth, supported by expanding healthcare infrastructure in China, India, and Southeast Asia. Terumo, Improve Medical, Weigao, and Narang Medical use local manufacturing and competitive pricing to win public tenders. Multinational Blood Collection Tubes market companies partner with regional players to balance regulatory compliance, pricing, and localization requirements.
Latin America and the Middle East & Africa are price-sensitive yet strategically important, with rising diagnostic capacity and investments in private hospital networks. Vacutest Kima, FL MEDICAL, Improve Medical, and Narang Medical compete on affordability and reliability, while global Blood Collection Tubes market companies selectively target premium hospital segments and leading private laboratory chains.
China is both a major production hub and a rapidly maturing demand center. Improve Medical and Weigao leverage scale, government relationships, and cost advantages to expand share. At the same time, BD and Terumo focus on high-end hospital segments, where demand favors premium safety products and robust quality assurance from established Blood Collection Tubes market companies.
Challengers & Emerging Players
Emerging Challengers & Disruptive Start-Ups
Cloud-based analytics platform that connects to tube labeling and automation systems to optimize tube utilization and reduce pre-analytical errors.
Developing bio-based, recyclable blood collection tubes aimed at reducing plastic waste while maintaining performance and regulatory compliance.
Offers ultra-low-cost, safety-focused capillary and vacuum tubes tailored for community health programs and mobile diagnostic camps.
Using nano-coatings inside tubes to stabilize fragile biomarkers, enabling longer transport times for advanced molecular and oncology testing.
Regional manufacturer integrating local resin sourcing with flexible OEM production to supply mid-tier hospitals and laboratories across Latin America.
Blood Collection Tubes Market Future Outlook & Key Success Factors (2026-2032)
From 2025 to 2031, cumulative investments in metro expansions and station safety upgrades are projected to surpass significant amounts. The total market will scale from US$ 2.27 Billionin 2025 to US$ 3.38 Billion by 2031, reflecting a 6.90% CAGR. Winning Blood Collection Tubes market companies will share several attributes. First, they will embed native IoT sensors, enabling predictive maintenance contracts that can double recurring revenue within five years. Second, modular design philosophies—interchangeable panels, plug-and-play controllers—will shorten installation windows and appeal to cost-sensitive public operators.
Localization strategies will also define competitive edges. Suppliers that establish regional assembly plants to meet content rules in India, Brazil, or the U.S. are likely to capture bonus points in tenders. Finally, sustainability credentials will move from optional to mandatory. Recyclable composite panels, energy-efficient brushless motors, and life-cycle carbon disclosures will become bid differentiators. In short, the coming decade rewards Blood Collection Tubesmarket companies that marry digital intelligence with manufacturing agility and regulatory foresight.
Frequently Asked Questions
Find answers to common questions about this company report.